Related Experiment Videos
BACE1 gene expression and protein degradation
Weihui Zhou1, Hong Qing, Yigang Tong
1Department of Psychiatry, Brain Research Center, University of British Columbia, Vancouver, Canada. weihong@interchange.ubc.ca
Annals of the New York Academy of Sciences
|February 1, 2005
Summary
Alzheimer's disease involves amyloid beta protein. This study reveals that the BACE1 enzyme, crucial for amyloid beta production, is regulated by the transcription factor Sp1 and the ubiquitin-proteasome pathway for degradation.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) protein deposition in the brain.
- Aβ is proteolytically cleaved from the amyloid precursor protein (APP) by beta-secretase (BACE1) and gamma-secretase.
- BACE1 is a key enzyme in Aβ generation and a potential therapeutic target for AD.
Purpose of the Study:
- To investigate the transcriptional regulation of BACE1 gene expression.
- To elucidate the role of the transcription factor Sp1 in BACE1 regulation.
- To explore the involvement of the ubiquitin-proteasome pathway in BACE1 protein degradation.
Main Methods:
- Analysis of the BACE1 promoter region, identifying it as TATA-less.
- Investigating the role of Sp1 in regulating BACE1 transcription.
- Studying the ubiquitination of BACE1 and its degradation via the ubiquitin-proteasome system.
Main Results:
- BACE1 gene expression is tightly controlled at the transcriptional level.
- The transcription factor Sp1 significantly contributes to the regulation of BACE1 expression.
- BACE1 protein undergoes ubiquitination, and its degradation is mediated by the ubiquitin-proteasome pathway, influencing APP processing.
Conclusions:
- BACE1 gene expression is regulated by a TATA-less promoter, with Sp1 playing a critical role.
- The ubiquitin-proteasome pathway is involved in the degradation of BACE1, impacting APP processing and Aβ production.
- Understanding these regulatory mechanisms offers insights into potential therapeutic strategies for Alzheimer's disease.